Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Vitamin D3 and Reduced Wart Recurrence

Doses used in studies

IU/session: 600,000 (median 600,000, IQR 600,000–600,000) — 1 study

Time to effect

Median: 8 weeks · IQR 8 weeks–8 weeks · Range 8 weeks–8 weeks — Reported in 1 of 1 study

Safety in these studies

itchingReported
Thirteen people experienced adverse symptoms, most noticeably minor swelling and itching.
from: The efficacy of intralesional vitamin D3 injection in the treatment of cutaneous warts: A
swellingReported
Thirteen people experienced adverse symptoms, most noticeably minor swelling and itching.
from: The efficacy of intralesional vitamin D3 injection in the treatment of cutaneous warts: A

1 of 1 paper

The efficacy of intralesional vitamin D3 injection in the treatment of cutaneous warts: A clinical therapeutic trial study.
- 2023-08
- Clinical Trial · n = 204
- Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) 29(8)
- - Haider Al-Sabak
  - Mohammed Al-Hattab
  - Marwah Al-Rammahi
  - Muhsin Al-Dhalimi
- PubMed: 37632174
- DOI: 10.1111/srt.13442
3 Insights on
- Reduced Wart Recurrence
- High evidence
- Large Human Trial
- Clinical
Within 6 months of follow-up, warts had completely disappeared for all patients with a partial or modest response except one who had no reaction
Effect
Beneficial
Effect size
Large
Dose
600,000 IU per session injected intralesionally every 2 weeks for 4 sessions